BCR:ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN AND ADOLESCENTS: INCREASED DISEASE BURDEN IN PATIENTS WITH JAK2 MUTATION, UNMET DIAGNOSTIC NEEDS AND OPTIMAL TREATMENT OPTIONS

Antzeko izenburuak

• BCR:ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN AND ADOLESCENTS: INCREASED DISEASE BURDEN IN PATIENTS WITH JAK2 MUTATION, UNMET DIAGNOSTIC NEEDS AND OPTIMAL TREATMENT OPTIONS
  nork: Charikleia Kelaidi, et al.
  Argitaratua: (2023-12-01)
• A CASE OF KRAS-MUTATED JMML WITH HIGH METHYLATION PROFILE AND PERPLEXED CLINICAL COURSE.
  nork: Vasiliki Tzotzola, et al.
  Argitaratua: (2023-12-01)
• IMMUNOPHENOTYPE IN SAMD9/9L SYNDROME: CORRELATIONS WITH MORPHOLOGY
  nork: Charikleia Kelaidi, et al.
  Argitaratua: (2023-12-01)
• THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP
  nork: Loizos Petrikkos, et al.
  Argitaratua: (2023-12-01)
• Hematopoetic Stem Cell Transplantation (HSCT) in pediatric patients with Severe Aplastic Anemia (SAA): the Greek experience
  nork: Kastamoulas Michalis, et al.
  Argitaratua: (2025-12-01)